Trademark: 97697312
Word
X
Status
Pending
Status Code
730
Status Date
Wednesday, May 22, 2024
Serial Number
97697312
Mark Type
3
Filing Date
Wednesday, November 30, 2022
Published for Opposition
Tuesday, October 31, 2023

Trademark Owner History
Telocyte, LLC - Owner At Publication

Classifications
5 Gene therapy products, namely, viral vectors with human genes for treating age-related diseases such as Alzheimer's disease
44 Medical services in the field of clinical gene therapy
42 Gene therapy research
The mark consists of two crossed lines in an "X" formation, the two right-hand horizontal arms of the "crossed lines" reaching about half the height of the two left-hand horizontal arms of the "crossed lines", with a short horizontal line parallel to the two right horizontal arms of the "crossed lines" and lying between them.
Color is not claimed as a feature of the mark.

Trademark Events
Dec 22, 2022
New Application Office Supplied Data Entered
Dec 3, 2022
New Application Entered
Dec 23, 2022
Notice Of Design Search Code E-Mailed
Sep 9, 2023
Assigned To Examiner
Sep 21, 2023
Examiners Amendment -Written
Sep 21, 2023
Examiners Amendment E-Mailed
Sep 21, 2023
Notification Of Examiners Amendment E-Mailed
Sep 21, 2023
Examiner's Amendment Entered
Sep 22, 2023
Approved For Pub - Principal Register
Oct 11, 2023
Notification Of Notice Of Publication E-Mailed
Oct 31, 2023
Published For Opposition
Oct 31, 2023
Official Gazette Publication Confirmation E-Mailed
Dec 26, 2023
Noa E-Mailed - Sou Required From Applicant
May 22, 2024
Sou Teas Extension Received
May 22, 2024
Sou Extension 1 Filed
May 22, 2024
Sou Extension 1 Granted
May 23, 2024
Notice Of Approval Of Extension Request E-Mailed

Trademark Alertz updated from USPTO on 2030-01-24